News
-
Approval to start phase II study
LIDDS has received approval from the National Agency of Medicine and Ethical Committee in Finland to start a phase II study in patients with localized prostate cancer.
| ||
Approval to start phase II study
LIDDS has received approval from the National
Agency of Medicine and Ethical Committee in Finland to start a phase II study in patients with
localized prostate cancer.
| ||
